Napa Therapeutics Company

Napa Therapeutics is a biotechnology company focused on a novel target linked to one of the fundamental processes of aging. A privately held British Virgin Islands company with an office in the Isle of Man, Napa is developing small molecule drugs to address this target. Napa Therapeutics is a spinout from The Buck Institute for Research on Aging partnering with Juvenescence.


Industry: Small&Large Molecules
Headquarters: Los Angeles, California, United States
Founded Date: 2018
Employees Number: 1001-5000
Last Funding Date: 2018
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership